How much does the medical insurance negotiation drug prescribe affect the assessment of medical institutions?

Medical institutions no longer need to worry about prescribing too many drugs for the national medical insurance negotiation, which will affect the assessment of medical institutions! Recently, the National Medical Insurance Administration and the National Health Commission jointly issued the "Notice on Adapting to the Normalization of National Medical Insurance Negotiations and Continue to Do a Good Job in the Implementation of Negotiated Drugs" (hereinafter referred to as the "Notice"), which clarified the rational use of the national medical insurance negotiation drugs.
It is not included in the scope of assessment indicators such as the proportion of medicines in medical institutions and the average cost per time
.

Why don't the hospitals have to open some negotiated drugs?

Why don't the hospitals have to open some negotiated drugs?

The reporter learned in previous interviews that after the negotiation of drugs landed, some patients happily went to their designated medical institutions to prescribe drugs, but found that the drug hospitals they wanted to prescribe might not be available
.

A person in charge of the hospital explained to reporters that the hospital introduces drugs that are negotiated, mainly based on the characteristics of their own hospitals, and according to their own clinical needs, to introduce drugs that are in relatively large demand

List the negotiated drugs for reasonable use separately

List the negotiated drugs for reasonable use separately

The "Notice" clearly stated that medical institutions are the first person responsible for negotiating the clinical rational use of drugs
.

All medical insurance designated medical institutions shall implement the main responsibilities of rational drug use, establish a linkage mechanism between hospital drug allocation and medical insurance drug catalog adjustments, and should allocate all negotiated drugs, and shall not limit the total amount of medical insurance, limit the number of drugs used by medical institutions, the proportion of drugs, and the average number of times.

Establish a linkage mechanism between hospital drug allocation and medical insurance drug catalogue adjustments.

The health department should adjust and improve the evaluation mechanism for the use of drugs in medical institutions , and list the negotiated drugs that are reasonably used separately from the scope of evaluation indicators that affect their implementation, such as the proportion of drugs in medical institutions and the average cost per second
.

The health department should adjust and improve the drug use evaluation mechanism of medical institutions, and list the negotiated drugs that are reasonably used.

Timely update the scope of "dual channel" drugs

Timely update the scope of "dual channel" drugs

The "Notice" also clarified that the availability of medicines should be improved through channels such as "dual channels"
.

Throughout the health care sector in accordance with the principle of strengthening the management, security of supply, regulate the use of strict supervision, the establishment of prescription circulation center, and on into the "dual-channel" unified management of the implementation of the drug reimbursement policy in designated retail pharmacies and medical institutions

A unified reimbursement policy will be implemented in designated retail pharmacies and designated medical institutions for drugs included in the "dual channel" management

By the end of November 2021, at least one qualified "dual channel" retail pharmacy will be realized by listing at each level.